{
  "ticker": "VRTX",
  "last_updated": "2025-04-19T07:17:27.853786",
  "retention_years": 3,
  "count": 128,
  "transactions": [
    {
      "id": 16066,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "225",
      "transaction_price": "418.10",
      "transaction_type": "F",
      "shares_after_transaction": "7740"
    },
    {
      "id": 5364,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3309",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "36939"
    },
    {
      "id": 5373,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3970",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "30052"
    },
    {
      "id": 5376,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-23",
      "transaction_shares": "2469",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "58329"
    },
    {
      "id": 5380,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-02-23",
      "transaction_shares": "828",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "8848"
    },
    {
      "id": 5381,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-23",
      "transaction_shares": "9386",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "136507"
    },
    {
      "id": 5388,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-23",
      "transaction_shares": "1654",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "16855"
    },
    {
      "id": 5389,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3309",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "56158"
    },
    {
      "id": 5392,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-23",
      "transaction_shares": "4714",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "54725"
    },
    {
      "id": 5399,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3309",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "53583"
    },
    {
      "id": 16068,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3309",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "36939"
    },
    {
      "id": 16078,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3970",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "30052"
    },
    {
      "id": 16081,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-23",
      "transaction_shares": "2469",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "58329"
    },
    {
      "id": 16085,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-02-23",
      "transaction_shares": "828",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "8848"
    },
    {
      "id": 16086,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-23",
      "transaction_shares": "9386",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "136507"
    },
    {
      "id": 16093,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-23",
      "transaction_shares": "1654",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "16855"
    },
    {
      "id": 16094,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3309",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "56158"
    },
    {
      "id": 16097,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-23",
      "transaction_shares": "4714",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "54725"
    },
    {
      "id": 16104,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3309",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "53583"
    },
    {
      "id": 5363,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-21",
      "transaction_shares": "360",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "59467"
    },
    {
      "id": 5367,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-21",
      "transaction_shares": "3603",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "59439"
    },
    {
      "id": 5384,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-21",
      "transaction_shares": "3002",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "34022"
    },
    {
      "id": 5390,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-21",
      "transaction_shares": "3191",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "60798"
    },
    {
      "id": 5396,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-21",
      "transaction_shares": "1201",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "18509"
    },
    {
      "id": 16067,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-21",
      "transaction_shares": "360",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "59467"
    },
    {
      "id": 16071,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-21",
      "transaction_shares": "3603",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "59439"
    },
    {
      "id": 16089,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-21",
      "transaction_shares": "3002",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "34022"
    },
    {
      "id": 16095,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-21",
      "transaction_shares": "3191",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "60798"
    },
    {
      "id": 16101,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-21",
      "transaction_shares": "1201",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "18509"
    },
    {
      "id": 19,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-20",
      "transaction_shares": "4118",
      "transaction_price": "420.58",
      "transaction_type": "F",
      "shares_after_transaction": "13778"
    },
    {
      "id": 5377,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-20",
      "transaction_shares": "4118",
      "transaction_price": "420.58",
      "transaction_type": "F",
      "shares_after_transaction": "13778"
    },
    {
      "id": 16082,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-20",
      "transaction_shares": "4118",
      "transaction_price": "420.58",
      "transaction_type": "F",
      "shares_after_transaction": "13778"
    },
    {
      "id": 1,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3498",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "70866"
    },
    {
      "id": 2,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "43060"
    },
    {
      "id": 4,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-16",
      "transaction_shares": "1501",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "21636"
    },
    {
      "id": 5,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-16",
      "transaction_shares": "9359",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "152912"
    },
    {
      "id": 8,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "59704"
    },
    {
      "id": 10,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "43838"
    },
    {
      "id": 16,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4499",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "63680"
    },
    {
      "id": 17,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4499",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "71219"
    },
    {
      "id": 5354,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3498",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "70866"
    },
    {
      "id": 5355,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "43060"
    },
    {
      "id": 5357,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-16",
      "transaction_shares": "1501",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "21636"
    },
    {
      "id": 5358,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-16",
      "transaction_shares": "9359",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "152912"
    },
    {
      "id": 5361,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "59704"
    },
    {
      "id": 5365,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "43838"
    },
    {
      "id": 5372,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4499",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "63680"
    },
    {
      "id": 5374,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4499",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "71219"
    },
    {
      "id": 16057,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3498",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "70866"
    },
    {
      "id": 16058,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "43060"
    },
    {
      "id": 16060,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-16",
      "transaction_shares": "1501",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "21636"
    },
    {
      "id": 16061,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-16",
      "transaction_shares": "9359",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "152912"
    },
    {
      "id": 16064,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "59704"
    },
    {
      "id": 16069,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "43838"
    },
    {
      "id": 16077,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4499",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "63680"
    },
    {
      "id": 16079,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4499",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "71219"
    },
    {
      "id": 24,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-14",
      "transaction_shares": "4356",
      "transaction_price": "419.04",
      "transaction_type": "S",
      "shares_after_transaction": "22551"
    },
    {
      "id": 5385,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-14",
      "transaction_shares": "4356",
      "transaction_price": "419.04",
      "transaction_type": "S",
      "shares_after_transaction": "22551"
    },
    {
      "id": 16090,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-14",
      "transaction_shares": "4356",
      "transaction_price": "419.04",
      "transaction_type": "S",
      "shares_after_transaction": "22551"
    },
    {
      "id": 7,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-12",
      "transaction_shares": "2009",
      "transaction_price": "419.22",
      "transaction_type": "S",
      "shares_after_transaction": "28291"
    },
    {
      "id": 5360,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-12",
      "transaction_shares": "2009",
      "transaction_price": "419.22",
      "transaction_type": "S",
      "shares_after_transaction": "28291"
    },
    {
      "id": 16063,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-12",
      "transaction_shares": "2009",
      "transaction_price": "419.22",
      "transaction_type": "S",
      "shares_after_transaction": "28291"
    },
    {
      "id": 9,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2100",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "68493"
    },
    {
      "id": 11,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-09",
      "transaction_shares": "832",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "24050"
    },
    {
      "id": 12,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2607",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "63454"
    },
    {
      "id": 18,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2100",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "46810"
    },
    {
      "id": 20,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "3177",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "80013"
    },
    {
      "id": 21,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "1588",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "20018"
    },
    {
      "id": 23,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8255",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "162271"
    },
    {
      "id": 27,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2022",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "77586"
    },
    {
      "id": 29,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "591",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "11050"
    },
    {
      "id": 30,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2099",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "50733"
    },
    {
      "id": 5362,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2100",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "68493"
    },
    {
      "id": 5366,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-09",
      "transaction_shares": "832",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "24050"
    },
    {
      "id": 5368,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2607",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "63454"
    },
    {
      "id": 5375,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2100",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "46810"
    },
    {
      "id": 5378,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "3177",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "80013"
    },
    {
      "id": 5379,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "1588",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "20018"
    },
    {
      "id": 5383,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8255",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "162271"
    },
    {
      "id": 5391,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2022",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "77586"
    },
    {
      "id": 5394,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "591",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "11050"
    },
    {
      "id": 5395,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2099",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "50733"
    },
    {
      "id": 16065,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2100",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "68493"
    },
    {
      "id": 16070,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-09",
      "transaction_shares": "832",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "24050"
    },
    {
      "id": 16072,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2607",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "63454"
    },
    {
      "id": 16080,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2100",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "46810"
    },
    {
      "id": 16083,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "3177",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "80013"
    },
    {
      "id": 16084,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "1588",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "20018"
    },
    {
      "id": 16088,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8255",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "162271"
    },
    {
      "id": 16096,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2022",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "77586"
    },
    {
      "id": 16099,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "591",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "11050"
    },
    {
      "id": 16100,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2099",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "50733"
    },
    {
      "id": 25,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-08",
      "transaction_shares": "2698",
      "transaction_price": "421.73",
      "transaction_type": "F",
      "shares_after_transaction": "38348"
    },
    {
      "id": 5386,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-08",
      "transaction_shares": "2698",
      "transaction_price": "421.73",
      "transaction_type": "F",
      "shares_after_transaction": "38348"
    },
    {
      "id": 16091,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-08",
      "transaction_shares": "2698",
      "transaction_price": "421.73",
      "transaction_type": "F",
      "shares_after_transaction": "38348"
    },
    {
      "id": 3,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35116"
    },
    {
      "id": 6,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6976",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "63532"
    },
    {
      "id": 13,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "37852"
    },
    {
      "id": 14,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-06",
      "transaction_shares": "10464",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12887"
    },
    {
      "id": 15,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-06",
      "transaction_shares": "2326",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16205"
    },
    {
      "id": 22,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6976",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "55613"
    },
    {
      "id": 26,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49507"
    },
    {
      "id": 28,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6294",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16863"
    },
    {
      "id": 31,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-06",
      "transaction_shares": "14516",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "123227"
    },
    {
      "id": 32,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "2950",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9788"
    },
    {
      "id": 33,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "64628"
    },
    {
      "id": 5356,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35116"
    },
    {
      "id": 5359,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6976",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "63532"
    },
    {
      "id": 5369,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "37852"
    },
    {
      "id": 5370,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-06",
      "transaction_shares": "10464",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12887"
    },
    {
      "id": 5371,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-06",
      "transaction_shares": "2326",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16205"
    },
    {
      "id": 5382,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6976",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "55613"
    },
    {
      "id": 5387,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49507"
    },
    {
      "id": 5393,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6294",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16863"
    },
    {
      "id": 5397,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-06",
      "transaction_shares": "14516",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "123227"
    },
    {
      "id": 5398,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "2950",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9788"
    },
    {
      "id": 5400,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "64628"
    },
    {
      "id": 16059,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35116"
    },
    {
      "id": 16062,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6976",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "63532"
    },
    {
      "id": 16073,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "37852"
    },
    {
      "id": 16074,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-06",
      "transaction_shares": "10464",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12887"
    },
    {
      "id": 16076,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-06",
      "transaction_shares": "2326",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16205"
    },
    {
      "id": 16087,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6976",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "55613"
    },
    {
      "id": 16092,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49507"
    },
    {
      "id": 16098,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6294",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16863"
    },
    {
      "id": 16102,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-06",
      "transaction_shares": "14516",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "123227"
    },
    {
      "id": 16103,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "2950",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9788"
    },
    {
      "id": 16105,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "64628"
    }
  ]
}